WallStSmart

Option Care Health Inc (OPCH) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Option Care Health Inc stock (OPCH) is currently trading at $28.49. Option Care Health Inc PE ratio is 22.37. Option Care Health Inc PS ratio (Price-to-Sales) is 0.80. Analyst consensus price target for OPCH is $40.09. WallStSmart rates OPCH as Underperform.

  • OPCH PE ratio analysis and historical PE chart
  • OPCH PS ratio (Price-to-Sales) history and trend
  • OPCH intrinsic value — DCF, Graham Number, EPV models
  • OPCH stock price prediction 2025 2026 2027 2028 2029 2030
  • OPCH fair value vs current price
  • OPCH insider transactions and insider buying
  • Is OPCH undervalued or overvalued?
  • Option Care Health Inc financial analysis — revenue, earnings, cash flow
  • OPCH Piotroski F-Score and Altman Z-Score
  • OPCH analyst price target and Smart Rating
OPCH

Option Care Health Inc

NASDAQHEALTHCARE
$28.49
$0.08 (0.28%)
52W$24.23
$36.80
Target$40.09+40.7%

📊 No data available

Try selecting a different time range

IV

OPCH Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · Option Care Health Inc (OPCH)

Margin of Safety
-207.4%
Significantly Overvalued
OPCH Fair Value
$11.28
Graham Formula
Current Price
$28.49
$17.21 above fair value
Undervalued
Fair: $11.28
Overvalued
Price $28.49
Graham IV $11.28
Analyst $40.09

OPCH trades 207% above its Graham fair value of $11.28, indicating the stock may be overvalued at current levels.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

Option Care Health Inc (OPCH) · 10 metrics scored

Smart Score

53
out of 100
Grade: C-
Buy
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/sales, institutional own.. Concerns around operating margin and eps growth. Fundamentals are solid but monitor weak areas for improvement.

Option Care Health Inc (OPCH) Key Strengths (4)

Avg Score: 8.5/10
Price/SalesValuation
0.8010/10

Paying less than $1 for every $1 of annual revenue

Institutional Own.Quality
108.03%10/10

108.03% of shares held by major funds and institutions

Market CapQuality
$4.51B7/10

Mid-cap company balancing growth potential with stability

Return on EquityProfitability
15.20%7/10

Solid profitability: $15 profit per $100 equity

Supporting Valuation Data

Price/Sales (TTM)
0.798
Undervalued
EV/Revenue
0.964
Undervalued
OPCH Target Price
$40.09
21% Upside

Option Care Health Inc (OPCH) Areas to Watch (6)

Avg Score: 3.3/10
Operating MarginProfitability
6.24%2/10

Very thin margins with limited operational efficiency

EPS GrowthGrowth
1.30%2/10

Earnings barely growing at 1.30%

Profit MarginProfitability
3.67%2/10

Very thin margins, barely profitable

Price/BookValuation
3.324/10

Premium pricing at 3.3x book value

Revenue GrowthGrowth
8.80%4/10

Modest revenue growth at 8.80%

PEG RatioValuation
1.546/10

Growth is fairly priced, not cheap, not expensive

Option Care Health Inc (OPCH) Detailed Analysis Report

Overall Assessment

This company scores 53/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 8.5/10) while 6 fall into concern territory (avg 3.3/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Sales, Institutional Own., Market Cap. Valuation metrics including Price/Sales (0.80) suggest the stock is attractively priced. Profitability is solid with Return on Equity at 15.20%.

The Bear Case

The primary concerns are Operating Margin, EPS Growth, Profit Margin. Some valuation metrics including PEG Ratio (1.54), Price/Book (3.32) suggest expensive pricing. Growth concerns include Revenue Growth at 8.80%, EPS Growth at 1.30%, which may limit upside. Profitability pressure is visible in Operating Margin at 6.24%, Profit Margin at 3.67%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 15.20% currently healthy but needing to be sustained. Third, growth sustainability, with Revenue Growth at 8.80% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Mixed fundamentals with both positives (Price/Sales, Institutional Own.) and negatives (Operating Margin, EPS Growth). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

OPCH Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

OPCH's Price-to-Sales ratio of 0.80x trades 27% below its historical average of 1.1x (52th percentile). The current valuation is 82% below its historical high of 4.41x set in Jun 2013, and 369% above its historical low of 0.17x in Dec 2016. Over the past 12 months, the PS ratio has compressed from ~0.9x as trailing revenue scaled faster than the stock price.

Compare OPCH with Competitors

Top MEDICAL CARE FACILITIES stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Option Care Health Inc (OPCH) · HEALTHCAREMEDICAL CARE FACILITIES

The Big Picture

Option Care Health Inc is a mature, profitable business with steady cash generation. Revenue reached 5.6B with 9% growth year-over-year. Profit margins are strong at 367.0%, reflecting pricing power and operational efficiency.

Key Findings

Excellent Capital Efficiency

ROE of 1520.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.

Cash Flow Positive

Generating 17M in free cash flow and 36M in operating cash flow. Earnings are translating into actual cash generation.

What to Watch Next

Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact Option Care Health Inc.

Bottom Line

Option Care Health Inc is a well-established business delivering consistent profitability with 367.0% margins. The growth phase may be slowing, but strong cash generation and operational efficiency make it suitable for investors seeking reliability over excitement.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions

Loading insider activity...

About Option Care Health Inc(OPCH)

Exchange

NASDAQ

Sector

HEALTHCARE

Industry

MEDICAL CARE FACILITIES

Country

USA

Option Care Health, Inc. offers infusion services at home and at alternative sites in the United States. The company is headquartered in Bannockburn, Illinois.